Protecting Synaptic Connectivity In Alzheimer's Disease
Funder
National Health and Medical Research Council
Funding Amount
$573,573.00
Summary
In Alzheimer’s disease, connections between neurons (synapses) are progressively damaged. The BACE inhibitor class of drugs entering Phase III clinical trials may slow the pace of neurodegeneration in patients with dementia. However, these drugs may simultaneously have negative effects on synapse function, learning and memory. This study will assess the effect of BACE inhibition on synapse properties and cognition and identify the contribution of key proteins affected by this treatment.
Combined TMS-EEG For Early Diagnosis Of Alzheimer’s Disease
Funder
National Health and Medical Research Council
Funding Amount
$603,767.00
Summary
Early diagnosis of Alzheimer's disease is key to more effective early intervention. Current biomarkers are expensive and are not suited for detecting the subtle changes in brain function that occur during the initial stages of the disease. Non-invasive brain stimulation is pain-free and inexpensive, and can directly probe brain function in conscious humans. This project will investigate whether these techniques might be used to identify markers of early brain dysfunction in Alzheimer’s disease.